As reported by the Senate Committee on Health, Education, Labor, and Pensions on February 1, 2024
By Fiscal Year, Millions of Dollars
2024
2024-2029
2024-2034
Direct Spending (Outlays)
0
0
0
Revenues
0
0
0
Increase or Decrease (-) in the Deficit
0
0
0
Spending Subject to Appropriation (Outlays)
0
1,079
not estimated
Increases net direct spending in any of the four consecutive 10-year periods beginning in 2035?
No
Statutory pay-as-you-go procedures apply?
No
Mandate Effects
Increases on-budget deficits in any of the four consecutive 10-year periods beginning in 2035?
No
Contains intergovernmental mandate?
No
Contains private-sector mandate?
No
Summary
S. 1840 would reauthorize the appropriation of $275 million each year from 2024 to 2028 for the National Breast and Cervical Cancer Early Detection Program, which is administered by the Centers for Disease Control and Prevention (CDC). Under the program, CDC provides grants to states to support access to screening, diagnosis, and treatment of breast and cervical cancer. The bill also would expand the eligible purposes for those grants and amend the program’s evaluation and reporting requirements. In 2024, CDC allocated $235.5 million for the program. In addition, S. 1840 would require the Government Accountability Office (GAO) to report to the Congress on the program’s operations.
Based on the costs of similar activities, CBO estimates that it would cost less than $500,000 for GAO to complete the required report. Assuming appropriation of the specified and estimated amounts, and using historical spending patterns for similar activities, CBO estimates that implementing S. 1840 would cost $1.1 billion over the 2024-2029 period.
